- Home
- EHI vs ORMP Comparison
EHI vs ORMP Comparison
Compare EHI & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EHI | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.2M | 170.3M |
| IPO Year | 2003 | 2010 |
Fundamental Metrics
Financial Performance| Metric | EHI | ORMP |
|---|---|---|
| Price | $5.84 | $4.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 91.0K | ★ 155.4K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.66 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $5.75 | $2.05 |
| 52 Week High | $6.70 | $5.19 |
Technical Indicators
Market Signals| Indicator | EHI | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 42.95 | 67.42 |
| Support Level | $5.80 | $3.91 |
| Resistance Level | $6.03 | $5.10 |
| Average True Range (ATR) | 0.05 | 0.21 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 44.39 | 90.89 |
Price Performance
Historical ComparisonAbout EHI Western Asset Global High Income Fund Inc
Western Asset Global High Inc Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is high current income. The Fund's secondary investment objective is total return. It invests in an international portfolio of securities consisting of below-investment-grade fixed income securities, emerging market fixed income securities, and investment-grade fixed income securities. The Fund's investment portfolio comprises sovereign bonds, collateralized mortgage obligations, asset-backed securities, and fixed income securities from different corporate sectors, including financials, energy, consumer discretionary, and industrials, among others.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.